Toripalimab is under investigation in clinical trial NCT03919383 (Phase II of Lenvatinib Plus Toripalimab for Advanced HCC).
Toripalimab is under investigation in clinical trial NCT03919383 (Phase II of Lenvatinib Plus Toripalimab for Advanced HCC).
⑴用于治疗既往标准治疗失败后的局部进展或转移性黑色素瘤。⑵用于治疗既往接受过二线及以上系统治疗失败的复发/转移性鼻咽癌(NPC)。⑶用于治疗既往接受过治疗的局部进展或转移性尿路上皮癌(UC)。⑷用于食管鳞癌一线治疗。
No associated conditions information available.
Sign in to access the complete clinical trial database with detailed study information.
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2020/05/13 | Phase 2 | UNKNOWN | |||
2020/05/06 | Phase 3 | Recruiting | Cancer Hospital of Guangxi Medical University | ||
2020/05/05 | Phase 1 | Recruiting | |||
2020/04/29 | Phase 2 | Recruiting | |||
2020/04/28 | Phase 3 | Recruiting | Sun Yat-sen University | ||
2020/04/27 | Phase 2 | UNKNOWN | Taizhou Hospital | ||
2020/04/24 | Phase 2 | Completed | Shanghai Zhongshan Hospital | ||
2020/04/22 | Phase 1 | Completed | |||
2020/04/21 | Phase 2 | UNKNOWN | |||
2020/04/08 | Phase 2 | UNKNOWN | Beijing Tongren Hospital |
Sign in to access additional FDA-approved products with detailed regulatory information.
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
---|
No FDA products found for this drug
Sign in to access additional EMA-approved products with authorization details.
Product Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
---|
No EMA products found for this drug
Sign in to access additional HSA-approved products with regulatory information.
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval Number |
---|
No HSA products found for this drug
Sign in to access additional NMPA-approved products with approval information.
Product Name | Approval Number | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
---|
No NMPA products found for this drug
Product Name | Registration Code | Company | Category | Sale Type | Registration Date |
---|---|---|---|---|---|
HK-68405 | Part 1, Schedule 1 & Schedule 3 Poison | POM | 2024/10/11 |
Sign in to access additional TGA-approved products with licensing information.
Product Name | ARTG ID | Sponsor | Status | Registration Date | Ingredient |
---|
No TGA products found for this drug